capital markets as it accelerates the development of its proprietary molecular diagnostic
platforms and solutions for microbiology.
Initial applications of molecular diagnostics
were mostly for infections but are now increasing in the areas of genetic disorders, preimplantation screening and cancer.
This view, which may already have been relatively unfair at the time, has been challenged since then by the application of molecular diagnostic
approaches, providing "pathognomonic" evidence of disease, such as the detection of specific translocations in fine-needle aspiration samples from lymphomas or sarcomas.
Detailed presentation on various molecular diagnostic
techniques was given to familiarize the participants with state of the art technology.
As part of the collaboration, tests from Fast-track Diagnostics' comprehensive infectious disease menu will be developed for use on Biocartis' innovative molecular diagnostics
(MDx) platform, Idylla.
is empowered by continual advancements in technology.
(1) The molecular diagnostics
sector of the market is expanding at a particularly robust clip, estimated to reach $8 billion by 2018 at a CAGR of $9.7 percent.
The technologies that constitute molecular diagnostics
- like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels - are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy.
The company designs and develops molecular diagnostics
for the healthcare industry, specialising in the automation of multiplexed molecular assays and customdesigned image analysis and interpretation software.
I believe four major drivers have enabled molecular diagnosticians to set up shop full time on Main Street: automated molecular testing systems; expanded commercial assay menus for infectious diseases; the emergence of personalized medicine approaches in cancer care; and improved education in genetics and molecular diagnostics
for both laboratorians and clinicians.
"XDx is a pioneer in the field of molecular diagnostics
," said Christopher A.
He said: "The platform is uniquely lowcost for both hardware and consumables and so represents an exciting new approach to bringing the advantages of molecular diagnostics
to resource limited settings.